Spin of the Day: August 17, 2007

August 17, 2007

When Drug Industry Flacks Attack

Following Dr. Steven Nissen's publication of a study warning that "GlaxoSmithKline's diabetes drug Avandia increased the risk of heart attacks by 43% and death from cardiovascular events by possibly 64%," he was publicly pilloried. "More than one story from ostensibly different sources" derisively referred to him as "St Steven," the "Patron Saint of Drug Safety," and "Saint Steven the Pure," reports Evelyn Pringle. Among the attackers was FDA spokesman Douglas Arbesfeld. Arbesfeld previously worked at the PR firm Manning Selvage & Lee (MS&L), helping Glaxo and other "healthcare clients maximize internet-relations." Former FDA Deputy Commissioner Dr. Scott Gottlieb, who ridiculed Nissen in a Wall Street Journal editorial, also consulted for pharmaceutical companies at MS&L. Two more FDA alums, Peter Pitts and Robert Goldberg, mocked Nissen in a Washington Times piece. Pitts is the senior vice-president for global health affairs at MS&L. Goldberg doesn't have ties to the PR firm, but serves with Pitts as an officer of the Center for Medicine in the Public Interest, which Pringle describes as a "nest of ex-moles who served the industry in one capacity or another in the Bush Administration's FDA." It's a project of the Pacific Research Institute, a corporate-funded think tank.


Edelman Reps Diebold's Not-So-Amicable Split

The PR firm Edelman "is handling the recasting of Diebold Election Systems to Premier Election Solutions," following the parent company's failure to sell its e-voting subsidiary. PES "will have its own management team and board of directors," and is based in Allen, Texas, while Diebold headquarters are in Ohio. Diebold blamed the lack of buyers on "rapidly evolving political uncertainties and controversies surrounding ... electronic voting systems." Diebold also lowered its e-voting revenue expectations by $120 million, according to Crain's Cleveland Business. A Diebold spokesman "acknowledged that the highly charged attention paid to the subsidiary ... has been a distraction to Diebold." The parent company now hopes to "concentrate on its core ATM and security segments."